Quantitative justification for target concentration intervention – parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides
- 4 June 2004
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 58 (1), 8-19
- https://doi.org/10.1111/j.1365-2125.2004.02114.x
Abstract
[1] To quantify the random and predictable components of variability for aminoglycoside clearance and volume of distribution [2] To investigate models for predicting aminoglycoside clearance in patients with low serum creatinine concentrations [3] To evaluate the predictive performance of initial dosing strategies for achieving an aminoglycoside target concentration. Aminoglycoside demographic, dosing and concentration data were collected from 697 adult patients (> or =20 years old) as part of standard clinical care using a target concentration intervention approach for dose individualization. It was assumed that aminoglycoside clearance had a renal and a nonrenal component, with the renal component being linearly related to predicted creatinine clearance. A two compartment pharmacokinetic model best described the aminoglycoside data. The addition of weight, age, sex and serum creatinine as covariates reduced the random component of between subject variability (BSVR) in clearance (CL) from 94% to 36% of population parameter variability (PPV). The final pharmacokinetic parameter estimates for the model with the best predictive performance were: CL, 4.7 l h(-1) 70 kg(-1); intercompartmental clearance (CLic), 1 l h(-1) 70 kg(-1); volume of central compartment (V1), 19.5 l 70 kg(-1); volume of peripheral compartment (V2) 11.2 l 70 kg(-1). Using a fixed dose of aminoglycoside will achieve 35% of typical patients within 80-125% of a required dose. Covariate guided predictions increase this up to 61%. However, because we have shown that random within subject variability (WSVR) in clearance is less than safe and effective variability (SEV), target concentration intervention can potentially achieve safe and effective doses in 90% of patients.Keywords
This publication has 38 references indexed in Scilit:
- COMMENTARY ON BROWN ET AL.'S “TOWARD A METABOLIC THEORY OF ECOLOGY”Ecology, 2004
- Aminoglycoside Dosage Regimens After Therapeutic Drug MonitoringClinical Pharmacokinetics, 2002
- Target concentration intervention: beyond Y2KBritish Journal of Clinical Pharmacology, 1999
- Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once dailyBritish Journal of Clinical Pharmacology, 1999
- Comparison of two Bayesian approaches to dose‐individualization for once‐daily aminoglycoside regimensBritish Journal of Clinical Pharmacology, 1997
- A Size Standard for PharmacokineticsClinical Pharmacokinetics, 1996
- Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside clearance as by creatinine clearance in critically ill patientsCritical Care Medicine, 1991
- Some suggestions for measuring predictive performanceJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976